Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells
about
The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectivesThe effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma.CD74 interferes with the expression of fas receptor on the surface of lymphoma cellsThe combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia.Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells.Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies.Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.Chronic lymphocytic leukaemia--the role of the microenvironment pathogenesis and therapy.The role of chemotherapy in managing chronic lymphocytic leukemia: optimizing combinations with targeted therapy.Targeted liposomal drug delivery systems for the treatment of B cell malignancies.Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells.The biological function and significance of CD74 in immune diseases.A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted delivery.CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice.Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma.
P2860
Q24628178-64DB2788-0C63-44A1-9BAE-C96F55D21878Q30498202-1052C16E-7DD8-46EE-ACC5-72208C1187C0Q34409837-1D61CC65-E2EA-4D83-A669-072E2C03E33DQ34470502-54B5F1D7-A704-43E0-9B41-45E7AC2B2589Q34997715-16BBAC78-65F4-439F-AD97-8D594F2CC142Q35958283-A326E149-B71B-4341-A4E9-635927FF64C3Q36512593-09EFC581-1D57-409E-9591-7C7B0715760FQ37129235-E001B36F-FA5D-4558-BC05-B8B505141987Q37221480-DE13559B-1712-4E73-82B6-078720207CA4Q37727030-A9732CC1-E3AB-43F0-B91E-F541CA9F0E50Q37910914-5F1AD6EC-0B98-4B6C-B681-6F7D9D9DE42DQ38101683-139BF4D8-FBA6-4767-A5D8-AE2C22A0BD5BQ38126946-80E512DA-9888-4F52-8A31-FF7898BAAEF6Q38179032-1BEFC9F5-824A-47E3-B833-720C8255573DQ38931196-54F20B54-82A1-47FE-B8BE-FF2B1627F84CQ38983516-22E05CAE-BBFA-470E-9C75-C54A39C7D7F3Q39106527-EBAAF34B-B575-4206-A2A2-DA5440FA1073Q48216696-2E232C4E-998B-4A32-9709-E58F0F7B99D3Q50765392-9B37192F-5122-4F51-B8B0-EEA5964F6111
P2860
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Milatuzumab immunoliposomes in ...... CD74 on the surface of B cells
@ast
Milatuzumab immunoliposomes in ...... CD74 on the surface of B cells
@en
Milatuzumab immunoliposomes in ...... CD74 on the surface of B cells
@nl
type
label
Milatuzumab immunoliposomes in ...... CD74 on the surface of B cells
@ast
Milatuzumab immunoliposomes in ...... CD74 on the surface of B cells
@en
Milatuzumab immunoliposomes in ...... CD74 on the surface of B cells
@nl
prefLabel
Milatuzumab immunoliposomes in ...... CD74 on the surface of B cells
@ast
Milatuzumab immunoliposomes in ...... CD74 on the surface of B cells
@en
Milatuzumab immunoliposomes in ...... CD74 on the surface of B cells
@nl
P2093
P2860
P1433
P1476
Milatuzumab immunoliposomes in ...... CD74 on the surface of B cells
@en
P2093
David Jarjoura
David M Goldenberg
David M Lucas
Ellen J Sass
Erin Hertlein
Georgia Triantafillou
Joshua D Hessler
Natarajan Muthusamy
Robert J Lee
Xiaoli Zhang
P2860
P304
P356
10.1182/BLOOD-2009-11-253203
P407
P50
P577
2010-06-23T00:00:00Z